Drugs / Cortisone acetate

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) CORTONE — 1950-06-13 fda.gov ↗

Trials 3

194919501951195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT06260462 Jan 2012 → Sep 2022 adrenocortical insufficiency University of Palermo Completed No outcome recorded
Phase 41 trial
Phase 4 NCT03760835 Aug 2016 → Dec 2026 expected classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Federico II University Recruiting No outcome recorded
Phase not applicable1 trial
— NCT05086926 Oct → Dec 2021 pes anserinus tendinitis or bursitis, tendinitis Aalborg University Unknown No outcome recorded
Comparator or background therapy10 trials
Phase 2 NCT01771328 Comparator Feb 2013 → Jan 2017 congenital adrenal hyperplasia Haukeland University Hospital Unknown No outcome recorded
Phase 2 NCT01154361 Comparator — angioedema Technical University of Munich Completed Met primary
Phase 2/3 NCT03580148 Comparator Oct 2015 → Jul 2020 osteoarthritis Women's College Hospital Completed No outcome recorded
Phase 3 NCT01843530 Background Nov 2013 → Oct 2018 renin-angiotensin-aldosterone system-blocker-induced angioedema Technical University of Munich Completed No outcome recorded
Phase 4 NCT06178146 Background Sep 2023 → Nov 2024 — Jun Wang Unknown No outcome recorded

Evidence & citations 16 cited values

Every value below carries the sentence it was read from. 15 sources stand behind the page.

FieldValueCited text
Known as cortisone acetate “Cortisone Acetate (dose 25 to 37.5 mg) will be continued as before entering the study.” NCT02277587 ↗
4

“conventional GCs (cortisone acetate or hydrocortisone)” PMID 39171906 ↗ Aug 2024

NCT01843530 ↗

NCT03760835 ↗

NCT01771328 ↗

Known as Cortate ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as Cortelan ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as Cortisona ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as cortisone “The project manager will give the participants one injection with cortisone and lidocaine in the lateral hip at baseline.” NCT05086926 ↗
7

“Cortisone” NCT06178146 ↗

NCT02196155 ↗

NCT03580148 ↗

NCT01154361 ↗

NCT02918136 ↗

NCT00951236 ↗

NCT02639039 ↗

Known as Cortisone 21-acetate ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as Cortisone aceticum ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as Cortistab ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as Cortisyl ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as Cortone ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Known as NSC-49420 ChEMBL registry synonym — accepted as the source's own label CHEMBL1650 ↗
Action Activate “Glucocorticoid receptor agonist” CHEMBL1650 ↗
Action Restore “glucocorticoid and mineralocorticoid replacement” NCT01771328 ↗
Modality Other / unclassified “Cortisone (corticosteroid) injection into the lateral hip” PMID 28257614 ↗ Mar 2017
Route Intravenous “Cortisone + Clemastin (intravenous) and plazebo (subcutaneous)” NCT01154361 ↗
Target NR3C1 “Glucocorticoid receptor agonist” CHEMBL1650 ↗